In its third quarter financial report, San Diego-based Cytori said it has moved significantly closer to initiating its cardiovascular clinical trials," said Christopher J. Calhoun, chief executive officer of Cytori Therapeutics. The company is developing adipose stem cells in cardiovascular disease and for use in reconstructive surgery.
Houston based ThromboVision, Inc. has won the first annual Michael E. DeBakey Life Science Award, which carries a $50,000 cash prize to assist in propelling the company's technology toward commercial success.
The stent market will have a distinctly different look after Johnson & Johnson completes its acquisition of Conor ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
A German physician reports that people who have implanted pacemakers or defibrillators are not in danger of their ...
The integration of Volcano’s intravascular ultrasound imaging (IVUS) capabilities into GE Healthcare’s Innova all ...
Siemens Medical Solutions’ ACUSON Antares ultrasound system, premium edition, features shared service cardiology ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
What doesn’t kill us, so the saying goes, makes us stronger. Those of us lucky enough to walk away from tragedy with our ...
Cordis Corp. has received approval from the FDA to market its PRECISE Nitinol Stent and ANGIOGUARD Emboli Capture guide ...
ZOLL Medical Corp. has announced it is now shipping all models of the ZOLL M Series defibrillator that comply with 2005 ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Training physicians, especially cardiac specialists, has taken on an increasingly critical role. With more cardiologists, cardiovascular surgeons and vascular surgeons interpreting CT data, the need for proper training has increased exponentially in recent years.
Designed to speed cardiovascular workflow and help enhance patient care, the Xcelera R2.1 integrates examination results from key cardiology subspecialties, including interventional cardiology, cardiovascular ultrasound, ECG, nuclear cardiology, cardiac CT, cardiac MR and electrophysiology.
The tiny tools of interventional cardiology known as drug-eluting stents (which happen to comprise a gargantuan U.S ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
A guide wire-based occlusion device, the GuardDOG by Possis Medical enables physicians to quickly and effectively manage local blood flow while employing interventional techniques and devices to treat vascular disease. It features a 0.035-inch diameter guide wire, preferred for peripheral interventions, and a soft, compliant, CO2-filled balloon providing quick inflation and deflation.
Photos of medical images produced from a new 3-D volume rendering software have the appearance of something from a “Star ...
A new platform architecture for TeraRecon’s Aquarius suite of products, iNtuition is designed to deliver integration of advanced imaging workflow into the healthcare enterprise and features an improved and more powerful central rendering resource in the form of the VolumePro 2000, based on the company’s FALCON chipset.